Journal of Neuro-Oncology · 2010 · 36 citations · 36 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyNeuro-oncologyBrain TumorsCentral Nervous System Tumor PharmacotherapyDose SchedulingGlioblastomaNeuro-oncology Clinical TrialsRecurrent Brain TumorsGlioblastoma ChemotherapyGlioblastoma Clinical TrialsGlioblastoma Drug TherapyGlioma ChemotherapyTemozolomide Therapy
36
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Roger Stupp, Warren Mason, Martin J. van den Bent et al. · New England Journal of Medicine · 2005 · 21.6K citations · Full text
Roger Stupp, Monika E. Hegi, Warren Mason et al. · The Lancet Oncology · 2009 · 7.8K citations
<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma
Monika E. Hegi, Annie‐Claire Diserens, Thierry Gorlia et al. · New England Journal of Medicine · 2005 · 7.3K citations · Full text
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
Henry S. Friedman, Michael D. Prados, Patrick Y. Wen et al. · Journal of Clinical Oncology · 2009 · 2.4K citations
Medicine, Oncology, Pharmacology +17
Response criteria for phase II studies of supratentorial malignant glioma.
David R. Macdonald, T L Cascino, S. Clifford Schold et al. · Journal of Clinical Oncology · 1990 · 2.4K citations